Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Induction of mismatch repair deficiency, compromised DNA damage signaling and compound hypermutagenesis by a dietary mutagen in a cell-based model for Lynch syndrome. | Carcinogenesis | 2022 | 34919656 | PubTator, text mining | PubMed |
| Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease. | Alzheimers Dement | 2022 | 34918867 | PubTator, text mining | PubMed |
| Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. | Adv Sci (Weinh) | 2022 | 34918496 | PubTator, text mining | PubMed |
| A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability. | Cancer | 2022 | 34875107 | PubTator, text mining | PubMed |
| Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program. | Cancer Discov | 2022 | 34862196 | PubTator, text mining | PubMed |
| How many is too many? Polyposis syndromes and what to do next. | Curr Opin Gastroenterol | 2022 | 34839308 | PubTator, text mining | PubMed |
| High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. | Transl Oncol | 2022 | 34837846 | PubTator, text mining | PubMed |
| Identification of SNPs in hMSH3/MSH6 interaction domain affecting the structure and function of MSH2 protein. | Biotechnol Appl Biochem | 2022 | 34837403 | PubTator, text mining | PubMed |
| Characterization of DNA damage response deficiency in pancreatic cancer patients from China. | Cancer Commun (Lond) | 2022 | 34821074 | PubTator, text mining | PubMed |
| Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer. | J Clin Lab Anal | 2022 | 34817097 | PubTator, text mining | PubMed |
| Evaluation of Classic, Attenuated, and Oligopolyposis of the Colon. | Gastrointest Endosc Clin N Am | 2022 | 34798989 | PubTator, text mining | PubMed |
| [Disease-modifying treatment approaches in Huntington disease : Past and future]. | Nervenarzt | 2022 | 34762178 | PubTator, text mining | PubMed |
| Similarity-Based Analysis of Allele Frequency Distribution among Multiple Populations Identifies Adaptive Genomic Structural Variants. | Mol Biol Evol | 2022 | 34718708 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of tumour microsatellite-instability status as a predictor of response to fluorouracil-based adjuvant chemotherapy in colorectal cancer. | Int J Colorectal Dis | 2022 | 34677685 | PubTator, text mining | PubMed |
| Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers. | Haematologica | 2022 | 34615339 | PubTator, text mining | PubMed |
| Unboxing the molecular modalities of mutagens in cancer. | Environ Sci Pollut Res Int | 2022 | 34611806 | PubTator, text mining | PubMed |
| Expanded CAG/CTG repeats resist gene silencing mediated by targeted epigenome editing. | Hum Mol Genet | 2022 | 34494094 | PubTator, text mining | PubMed |
| Radiation Response Prediction Model Based on Integrated Clinical and Genomic Data Analysis. | Cancer Res Treat | 2022 | 34425668 | PubTator, text mining | PubMed |
| Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway. | Recent Pat Anticancer Drug Discov | 2022 | 34365931 | PubTator, text mining | PubMed |
| Germline Alterations in Patients With IBD-associated Colorectal Cancer. | Inflamm Bowel Dis | 2022 | 34347074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=39